A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer)

NCT03337698 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

314

Enrollment

INDUSTRY

Sponsor class

Stopped Study was closed early as the sponsor decided not to continue development of certain treatment combinations.

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: Atezolizumab
DRUG: Cobimetinib
DRUG: RO6958688
DRUG: Docetaxel
DRUG: CPI-444
DRUG: Pemetrexed
DRUG: Carboplatin
DRUG: Gemcitabine
DRUG: Linagliptin
DRUG: Tocilizumab
DRUG: Ipatasertib
DRUG: Bevacizumab
DRUG: Sacituzumab Govitecan
OTHER: Radiation
DRUG: Evolocumab
DRUG: Tiragolumab
DRUG: XL092
DRUG: Camonsertib

Sponsor

Hoffmann-La Roche